Stock Events

Stock Events

Perseus Proteomics 

¥215
5
+¥1+0.47% Friday 06:01

Statistics

Day High
218
Day Low
213
52W High
466
52W Low
205
Volume
88,400
Avg. Volume
-
Mkt Cap
3.17B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-21.87
-18.29
-14.71
-11.13
Expected EPS
N/A
Actual EPS
N/A

Financials

-565.12%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
164.07MRevenue
-927.18MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 4882.TSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals is a leading biotech company focusing on developing monoclonal antibodies, directly competing with Perseus Proteomics' antibody research and development.
AMGEN
AMGN
Mkt Cap178B
Amgen is a biopharmaceutical company that develops innovative human therapeutics, including in the area of proteomics, making it a direct competitor.
Repligen
RGEN
Mkt Cap6.67B
Repligen Corporation provides bioprocessing technologies and solutions, including protein analysis and purification, competing in the proteomics space.
Illumina
ILMN
Mkt Cap20.63B
Illumina, Inc. specializes in DNA sequencing and array-based technologies, contributing to proteomics research and competing in the genomic and proteomic analysis market.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.45B
BioMarin Pharmaceutical focuses on enzyme replacement therapies and has a strong pipeline in protein-based therapeutics, competing in the same biopharmaceutical space.
Bio-Techne
TECH
Mkt Cap8.61B
Bio-Techne Corporation develops, manufactures, and sells biotechnology reagents and instruments for the research and clinical diagnostics markets, including proteomics research.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories operates in diagnostics, medical devices, nutritionals, and branded generic pharmaceuticals, including research in proteomics, making it a competitor.
Thermo Fisher Scientific
TMO
Mkt Cap174.37B
Thermo Fisher Scientific offers analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics, including in proteomics.
Danaher
DHR
Mkt Cap123.97B
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services, with a significant presence in life sciences and diagnostics, including proteomics tools.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a global biopharmaceutical company with a broad range of drug development that includes protein and antibody therapies, making it a competitor in the therapeutic protein space.

About

Perseus Proteomics Inc., a drug discovery bio-venture company, develops antibody drugs against cancer and other diseases in Japan. The company is involved in the antibody discovery, antibody engineering, target discovery, and functional protein expression activities; and antibody research support activities comprising mouse hybridoma sequencing, recombinant protein production, and contract antibody research activities, as well as development, manufacture, and supply of antibody products. Its product pipeline includes PPMX-T001 for treating liver cancer; PPMX-T002 for solid tumors; PPMX-T003 to treat hematologic cancer; and PPMX-T004 for solid tumor. The company was incorporated in 2001 and is headquartered in Tokyo, Japan.
Show more...
CEO
Takuya Yokokawa
Employees
21
Country
Japan
ISIN
JP3836800007

Listings

TSE
JP
4882.TSE

0 Comments

Share your thoughts

FAQ

What is Perseus Proteomics stock price today?▼
The current price of 4882.TSE is ¥215 JPY — it has increased by +0.47% in the past 24 hours. Watch Perseus Proteomics stock price performance more closely on the chart.
What is Perseus Proteomics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Perseus Proteomics stocks are traded under the ticker 4882.TSE.
Is Perseus Proteomics stock price growing?▼
4882.TSE stock has fallen by -1.38% compared to the previous week, the month change is a -4.87% fall, over the last year Perseus Proteomics has showed a -48.07% decrease.
What is Perseus Proteomics market cap?▼
Today Perseus Proteomics has the market capitalization of 3.17B
When is the next Perseus Proteomics earnings date?▼
Perseus Proteomics is going to release the next earnings report on May 14, 2026.
What were Perseus Proteomics earnings last quarter?▼
4882.TSE earnings for the last quarter are -11.13 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is Perseus Proteomics revenue for the last year?▼
Perseus Proteomics revenue for the last year amounts to 164.07M JPY.
What is Perseus Proteomics net income for the last year?▼
4882.TSE net income for the last year is -927.18M JPY.
How many employees does Perseus Proteomics have?▼
As of May 06, 2026, the company has 21 employees.
In which sector is Perseus Proteomics located?▼
Perseus Proteomics operates in the Health & Wellness sector.
When did Perseus Proteomics complete a stock split?▼
Perseus Proteomics has not had any recent stock splits.
Where is Perseus Proteomics headquartered?▼
Perseus Proteomics is headquartered in Tokyo, Japan.